Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomaras

Showing results (221-230 of 525) with videos related to

Pageof 53
Sort By:
Journal of Virology|February 21, 2014
Capacity for infectious HIV-1 virion capture differs by envelope antibody specificityPinghuang Liu, Latonya D Williams, Xiaoying Shen, et al.
Frontiers in Immunology|January 24, 2024
Defining genetic diversity of rhesus macaque Fcγ receptors with long-read RNA sequencingHaleigh E Conley, Max M He, David Easterhoff, et al.
Journal of Virology|November 12, 2020
Systematic Assessment of Antiviral Potency, Breadth, and Synergy of Triple Broadly Neutralizing Antibody Combinations against Simian-Human Immunodeficiency VirusesStella J Berendam, Tiffany M Styles, Papa K Morgan-Asiedu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2016
Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus MacaquesDonatella Negri, Maria Blasi, Celia LaBranche, et al.
Frontiers in Immunology|March 11, 2022
Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV ChallengesSamir K Lakhashe, Mario Amacker, Dinesh Hariraju, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2011
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primatesBarbara J Flynn, Kathrin Kastenmüller, Ulrike Wille-Reece, et al.
Journal of Virology|February 6, 2009
In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadthXiaoying Shen, Robert J Parks, David C Montefiori, et al.
Frontiers in Immunology|February 6, 2026
Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccineKasey Stokdyk, Anusmita Sahoo, Sailaja Gangadhara, et al.
Mbio|October 4, 2012
Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosisLin Lin, Brandon Tan, Paul Pantapalangkoor, et al.
Eclinicalmedicine|December 9, 2024
Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06)Yves Levy, Christiane Moog, Aurélie Wiedemann, et al.
Pageof 53

Showing results (221-230 of 525) with videos related to

Sort By:
Pageof 53
Journal of Virology|February 21, 2014
Capacity for infectious HIV-1 virion capture differs by envelope antibody specificityPinghuang Liu, Latonya D Williams, Xiaoying Shen, et al.
Frontiers in Immunology|January 24, 2024
Defining genetic diversity of rhesus macaque Fcγ receptors with long-read RNA sequencingHaleigh E Conley, Max M He, David Easterhoff, et al.
Journal of Virology|November 12, 2020
Systematic Assessment of Antiviral Potency, Breadth, and Synergy of Triple Broadly Neutralizing Antibody Combinations against Simian-Human Immunodeficiency VirusesStella J Berendam, Tiffany M Styles, Papa K Morgan-Asiedu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2016
Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus MacaquesDonatella Negri, Maria Blasi, Celia LaBranche, et al.
Frontiers in Immunology|March 11, 2022
Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV ChallengesSamir K Lakhashe, Mario Amacker, Dinesh Hariraju, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2011
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primatesBarbara J Flynn, Kathrin Kastenmüller, Ulrike Wille-Reece, et al.
Journal of Virology|February 6, 2009
In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadthXiaoying Shen, Robert J Parks, David C Montefiori, et al.
Frontiers in Immunology|February 6, 2026
Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccineKasey Stokdyk, Anusmita Sahoo, Sailaja Gangadhara, et al.
Mbio|October 4, 2012
Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosisLin Lin, Brandon Tan, Paul Pantapalangkoor, et al.
Eclinicalmedicine|December 9, 2024
Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06)Yves Levy, Christiane Moog, Aurélie Wiedemann, et al.
Pageof 53